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Background: Preliminary evidence suggests that metacognitive therapy (MCT), a brief, process-focused 
psychological intervention, alleviates distress in cancer survivors. In a longitudinal qualitative study nested 
in an open trial of MCT for cancer survivors, we explored how patients understood, experienced and applied 
MCT.  
Methods: Patients received six MCT sessions. Consenting patients provided semi-structured interviews 
post-intervention (n=19), and at 3- and 6-months follow-up (n=14 and 10 respectively). Interviews were 
audio-recorded and transcribed. Analysis followed a constant comparison approach.  
Results: Participants felt ”overwhelmed”  by worry before starting MCT and doubted that such brief 
therapy could help. Their accounts focused on feeling “challenged” to think differently by the psychologist. 
Those completing therapy were enthusiastic about it. They described having learned that thoughts are “only 
thoughts”, that feelings of worry or sadness are a normal part of life, and that they were in control of whether 
and how they engaged with thoughts. Consequently, most described a sense of freedom to live free from 
worry. A minority described being unable to apply MCT to certain thoughts. Two patients who withdrew 
before completing MCT did not describe having learned what MCT was intended to achieve.  
Conclusions: MCT is an acceptable brief intervention for distressed cancer survivors. Feeling challenged 
to understand the processes maintaining their distress was central to their enthusiasm for it, irrespective of 
their presenting difficulties.  
Implications for Cancer Survivors: The complexity of emotional distress in cancer survivors can 
potentially be addressed using a transdiagnostic model which focuses on the psychological processes which 
maintain distress.  
 
 
Keywords: Metacognition; cancer survivors; anxiety; depression; qualitative 
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INTRODUCTION 
Advances in early detection and treatment of cancer mean that, despite varying prognoses across 
different types of cancer, overall around 70% of patients diagnosed with cancer can be treated effectively 
and live for more than 5 years post-diagnosis (Cancer Research UK, 2017). Therefore there is increasing 
focus in health care policy and research on the challenges of cancer survivorship (Kline et al., 2018; Rohan 
et al., 2018). Given the shock of a cancer diagnosis, treatment that can be unpleasant and life-changing, and 
continued uncertainty over prognosis, it is unsurprising that emotional distress is common in adult cancer 
survivors, persisting well into survivorship (Carreira et al., 2018; Deimling, Kahana, Bowman, & Schaefer, 
2002). Specifically, around a third of cancer survivors experience clinically-significant emotional distress 
which warrants psychological intervention (Hoffman, McCarthy, Recklitis, & Ng, 2009). Over half also 
report moderate to high fear of cancer recurrence (Simard et al., 2013).  
Psychological distress reduces quality of life and treatment adherence, intensifies physical symptoms and 
increases healthcare cost (Carlson & Bultz, 2003; Carlson & Bultz, 2004; DiMatteo, Lepper, & Croghan, 
2000). National and international guidance therefore recommends psychological care for cancer patients 
who are distressed (Butow et al., 2015b; National Institute for Health and Care Excellence, 2009, 2017; 
NHS London, 2015). However, meta-analyses evaluating the efficacy of current psychological 
interventions in cancer populations have yielded only small to modest effect sizes (Demoncada & 
Feuerstein, 2006; Faller et al., 2013; Rehse & Pukrop, 2003; Temple et al., 2018). One possible explanation 
is that current approaches to psychological support for cancer patients and survivors tend to focus on the 
content of their negative thoughts. In particular, the current ‘gold standard’ treatment, cognitive behavioural 
therapy (CBT; National Institute for Health and Care Excellence, 2009), challenges the validity of intrusive 
negative thoughts that maintain distress, and of the negative beliefs that underlie those thoughts. However, 
in a physical health context, such as cancer care, many of the negative thoughts that distress patients reflect 
accurate fears associated with the disease or its effects, and are therefore less amenable to challenge 
(Edmondson, 2014). Furthermore, there is evidence that focusing on negative thoughts can itself create a 
sense of escalating danger that maintains, rather than reduces, emotional distress (Aldao, Nolen-Hoeksema, 
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& Schweizer, 2010; Nolen-Hoeksema, 1991; Riskind, Williams, & Joiner Jr., 2006). Therefore 
psychological approaches which do not primarily dispute the validity of negative thoughts but, instead, help 
patients to engage less with negative thoughts could  be more efficacious in reducing emotional distress in 
people with physical health conditions such as cancer.   
The main “third wave” CBT  approaches are Acceptance and Commitment Therapy (ACT; Hayes, 
Luoma, Bond, Masuda, & Lillis, 2006), Mindfulness-based cognitive therapy (MBCT; Teasdale, Segal, & 
Williams, 1995) and Mindfulness based stress reduction (MBSR; Kabat‐Zinn, 2003). However, each of 
these approaches does involve responding to and dealing with negative thoughts. MBCT has added 
mindfulness components to CBT, and therefore uses cognitive restructuring, psychoeducation and activity 
scheduling.  The core elements of are MBSR are meditation, yoga and mindful relaxation.  ACT has been 
described as a process based therapy (Hayes et al., 2006) incorporating a range of strategies including forms 
of meditation, awareness of negative thoughts, and changing avoidant behaviours to more positive ones by 
reflecting on patients’ valued life aims. Evidence for the efficacy of MBCT and MBSR for emotional 
distress in cancer patients is not established (Haller et al., 2017). ACT has shown more promise, but its 
effects are modest (Hulbert-Williams, Beatty, & Dhillon, 2018). Although none of these approaches 
principally involves disputation of negative thoughts, all still require patients to discuss the content of 
negative thoughts.  As mentioned above, key components of CBT are included in MBCT.  Both ACT and 
MBSR require identification of and discussion of the value and benefits of negative thoughts.  Each form 
of engagement with negative thoughts is a type of coping strategy, requiring continued processing of 
negative thoughts.  
Engagement with negative thoughts is, however, the antithesis of the aims of  Metacognitive therapy 
(MCT; Wells, 2000, 2009) which states that any form of coping strategy necessitates conceptual processing.  
MCT focuses, not on the content of patients’ concerns, but on the metacognitive processes and the beliefs 
that underlie them. Its premise is that these processes are controllable, and that patients can learn skills to 
alleviate their distress through a circumscribed, short-term intervention (Wells & Matthews, 1994). MCT 
is based on the Self-Regulatory Executive Function (S-REF) model (Wells & Matthews, 1994), which is a 
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transdiagnostic model of metacognitive processes and beliefs in psychopathology. This model states that 
emotional distress becomes persistent when stored metacognitive beliefs guide an individual to respond to 
commonly-occurring negative thoughts and feelings in a particular way. This is termed the cognitive-
attentional syndrome (CAS), and involves three processes: (i) perseverative thinking (i.e. worry and 
rumination); (ii) threat monitoring (i.e. focusing attention on potentially threatening thoughts, emotions or 
bodily sensations); and (iii) maladaptive coping strategies (such as avoidance and reassurance seeking). 
Common concerns in cancer patients are fear of recurrence or functional limitations associated with the 
disease and treatment. MCT does not challenge the content of these thoughts or use strategies which 
promote further engagement with those thoughts. Instead patients would be helped to understand the 
deleterious and counterproductive effects of the CAS, therefore enhancing motivation to suspend worry 
and rumination. Simultaneously, metacognitive beliefs about the uncontrollability of worry and rumination 
would be challenged. Modifying negative metacognitive beliefs is central to MCT because, as long as 
patients believe that perseverative thinking is uncontrollable, they will not try to control it.  
Cross-sectional and prospective studies indicate that metacognitive beliefs are associated with 
emotional distress and fear of cancer recurrence in adult cancer survivors (Butow et al., 2015a; Cook et al., 
2015a, 2015b; Thewes, Bell, & Butow, 2013) thus supporting the ‘fit’ of the S-REF model to this 
population. Furthermore, case series and open trials suggest that brief MCT is an effective and acceptable 
intervention for depression, anxiety and trauma symptoms in cancer survivors (Fisher, Byrne, & Salmon, 
2017; Fisher, McNicol, Young, Smith, & Salmon, 2015; Fisher et al., 2019; McNicol, Salmon, Young, & 
Fisher, 2012) with gains maintained for most patients through to 6-month follow-up (Fisher et al., 2015; 
Fisher et al., 2019). Although these findings point to the need for controlled evaluations of MCT, additional 
kinds of evidence are needed before progressing to more definitive trials. Qualitative methods can provide 
information about interventions that trials, alone, cannot. In particular, qualitative research can show how 
patients understand and experience an intervention (i.e. its ‘face validity’) and can help to understand why 
an intervention was successful (or not) in individual patients. Qualitative methods can also provide patients’ 
perspectives on how an intervention was delivered, thus enhancing understanding of its transferability 
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between clinical contexts (O'Cathain, Thomas, Drabble, Rudolph, & Hewison, 2013). The UK Medical 
Research Council therefore recommends that researchers use qualitative methods both to understand trial 
findings and to inform future intervention development, delivery and evaluation (Craig et al., 2008; Elliott, 
2010; Moore et al., 2015).  
In this study, we report the findings of qualitative research nested in an open trial of MCT for anxiety 
and depression in adult cancer survivors (Fisher et al., 2019). In this trial, patients received six one-hour 
sessions of MCT, delivered weekly. Patients completed measures of emotional distress, quality of life, 
worry/rumination, fear of cancer recurrence and metacognitive beliefs post-intervention, and at 3- and 6-
month follow-up (Fisher et al., 2019). We also interviewed consenting patients at each time point, to explore 
qualitatively: i) how they understood and experienced the intervention; ii) once treatment ended, how, and 
to what extent over the follow-up period, did patients transfer what they had learned across the range of 
emotional challenges arising during survivorship; and iii) what characterised any patients who did not 
benefit? Here we report this longitudinal qualitative study.  
METHOD  
Ethical approval was provided by the National Health Service North West Research Ethics Committee 
(reference 15/NW/0820).  
Participants 
Participants were patients referred to an adult clinical psycho-oncology service in the north of England, 
who i) had initiated MCT in the context of open trial of MCT for anxiety and depression (Fisher et al., 
2019), and ii) whom we could categorize as clinically improved or not (see below). Inclusion criteria for 
entering the open trial were that participants: i) scored ≥15 on the Hospital Anxiety and Depression Scale 
total (HADS; Zigmond & Snaith, 1983); ii) had been diagnosed with cancer ≥6 months previously; iii) were 
aged 18 years or over; iv) had completed acute medical treatment for cancer (i.e. chemotherapy, 
radiotherapy, surgery); v) were not receiving concurrent psychological treatment; vi) were not actively 
suicidal; vii) reported no current substance use; vii) were not experiencing a psychotic or organic illness; 
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viii) were free from psychotropic medication or on a stable dose for at least 8 weeks; and (viiii) were able 
to speak and understand English. Briefly, participation involved attending 6 one-hour sessions of MCT 
delivered over a 10-week period by AB, PF or one other female clinical psychologist (LF). PF supervised 
AB and LF. After treatment, participants were followed up at 3 and 6 months; no additional treatment was 
delivered during the follow-up period. Participants completed self-report questionnaires assessing a range 
of outcomes, including anxiety and depression, worry/rumination, fear of cancer recurrence and 
metacognitive beliefs, pre-intervention, post-intervention and at 3-and 6-month follow-up.  All 
questionnaires including the primary outcome (HADS-Total) were completed in face-to-face interviews 
and used pencil and paper format. For full details of each questionnaire see the report of the open trial 
(Fisher et al., 2019). 
In total, 43 consecutive referrals who appeared to meet inclusion criteria for the open trial were given 
further information about the trial. Of these, 33 agreed to be assessed for eligibility. Twenty-seven 
participants began the trial, all of whom consented to being approached for qualitative interviews post-
treatment and at 3- and 6-months follow-up. Our criterion for clinically significant improvement was ≥6 
points reduction in the HADS total score post-therapy and at 3- and 6-month follow up by comparison with 
pre-therapy (Jacobson & Truax, 1991). Twenty participants completed treatment, of whom 19 provided 3- 
and 6-month follow-up data and could therefore be categorized as improved or not. Of these 19, 15 met our 
criterion for improvement.  
Procedure 
We invited all 19 participants who had completed therapy and whom we could categorize as improved 
or not to participate in this qualitative study. We also made strenuous efforts to recruit the seven participants 
who did not complete therapy, whom we regarded as potentially key informants. HU, AB1 or GA 
interviewed consenting participants privately in a University office, hospital consulting room or by 
telephone, as each patient preferred. Interviews, loosely structured by an interview guide, were 
                                                          
1 AB did not interview patients whom she had seen for therapy   
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conversational, using open questions and prompts to facilitate participants’ talk, with closed questions 
probing specific points. Pace of the interview and sequencing of specific topics therefore depended on each 
participant. In general, after reviewing the participant’s cancer journey, the interviewer asked about 
emotional problems around the time of entry to the trial, expectations of MCT before starting therapy, and 
their experience, understanding and evaluation of MCT as therapy continued. To avoid generalized or 
normative accounts, the interviewer prompted participants to focus on specific sessions, and specific 
experiences in those sessions, and to recount in detail how they addressed specific emotional challenges 
during the period of therapy and, for follow-up interviews, subsequently. For participants who withdrew 
prematurely, the interviewer explained that we had much to learn from those who decided that MCT was 
not appropriate for them at that time, and explored the reasons for the participant’s decision as well as their 
expectations and experience of MCT. Interviews lasted 7-92 minutes (mean 40 minutes). 
Interviews were audio-recorded with participants’ permission, transcribed verbatim and anonymised. 
Participants were allocated a unique code number to preserve their anonymity. Analysis focused first on 
the participants who met our criterion for clinically significant improvement. Analysis was inductive in 
describing salient features of participants’ accounts, rather than applying an a priori categorization such as 
offered by the interview guide or metacognitive theory. Specifically, we identified aspects of their accounts 
which showed strong commonalities or, conversely, marked divergences.  
Analysis drew on a pluralist qualitative approach (Salmon & Young, 2018), in which we sought 
‘methodological integrity’ by adopting practices that ensured fidelity to the data and utility for the research 
question (Levitt, Motulsky, Wertz, Morrow, & Ponterotto, 2017). Analysis proceeded in parallel with 
interviews. MGC led analysis in frequent discussion with PS and PF, who read all the transcripts over the 
course of analysis; other authors read selected transcripts or extracts. MGC, PS and PF began by developing 
a preliminary thematic framework based on the first five participants’ post-treatment interviews. This was 
tested and refined in discussion and by reference to new transcripts so that the analysis developed 
iteratively, following a constant comparative approach (Fram, 2013). We used Microsoft Word to label and 
organize text using inductive headings that evolved over the analysis (Pelle, 2004). Analysis was based 
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initially on the post-treatment interviews, drawing on follow-up interviews as it proceeded and as they 
became available. The resulting framework provided a starting point for incorporating data from 
participants who did not meet our criterion for clinically-significant improvement and those who did not 
complete MCT. During the final stages of analysis, the analysis was tested and further developed by 
discussion amongst all authors. Throughout analysis, we took a ‘disputational’ approach, whereby we 
identified and developed competing interpretations and tested their validity by argumentation amongst the 
group that was grounded in the evidence of the transcripts. As analysis proceeded, we continually judged 
it according to consensus validity (through debate, it should satisfy all authors; Stiles, 1989), reflexive 
validity (it should change authors' initial and subsequent views; Stiles, 1989), catalytic validity (it should 
have potential practice implications; Kincheloe & McLaren, 2000; Stiles, 1989), and theoretical validity (it 
should connect with and helpt to test and develop existing theory; Kincheloe & McLaren, 2000; Stiles, 
1993). Analysis ended when we judged that the account we produced met these criteria and when further 
discussion and reference to the data did not appreciablymodify it.The team encompassed a range of 
backgrounds, allowing us to use these different perspectives to to inform “investigator triangulation” in 
analysis (Patton, 2015).  
GA and HU are research psychologists with experience in delivering CBT. AB, MGC, PF and PS are 
clinical psychologists; MGC has researched emotional processes in health care; AB has researched patient 
perspectives in cancer care and is trained in MCT. PF and PS have expertise, respectively, in applying MCT 
in physical health populations and in studying patients’ perspectives in cancer care. By drawing on these 
different perspectives we sought to ensure that analysis was inductive and robust, while subsequently 
interpreting its specific relevance to MCT.  
Representative extracts from interviews illustrate the main findings, below. Italicised text indicates 
direct quotes. For extended quotations, participants are identified by participant number and assessment 
occasion: 0, 3, 6 indicating immediately and 3- or 6-months post-therapy. Square parentheses indicate 
explanatory comments; ellipses indicate omitted talk. We first report those participants who met our 
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criterion for clinically-significant improvement; then we report those who did not complete therapy or who 
completed it but without meeting our criterion for improvement. 
RESULTS 
Sample characteristics 
Of the 19 participants who completed treatment and could be categorized as improved or not, 17 agreed 
to be interviewed post-treatment. Of these, 13 met the criterion for clinically-significant improvement. At 
3- and 6-months follow-up, 14 and 10 particpants respectively, could be contacted and agreed to be 
interviewed. Of the seven participants who did not complete MCT, two, who had attended one and three 
sessions respectively, provided a brief telephone interview after withdrawing from the trial.  
Most participants were female (n = 17) and White British (n = 18). Ten participants had been diagnosed 
with breast cancer. Most (n = 17) had undergone surgery, chemotherapy and/or radiotherapy. Fifteen 
participants had previous experience of psychological therapy; of these, eight had attended counselling, and 
an additional six had had CBT. Time since completing acute medical treatment ranged from 3 months to 
78 months. Participants’ pre-treatment HADS scores ranged from 20 to 38, with a mean of 25.47 and 
standard deviation of 6.33. Table 1 displays participants’ demographic and clinical characteristics and 
HADS scores.  
[Please insert Table 1 here] 
1 Participants who completed therapy and consistently improved 
 In summary, these participants described their starting point of intense worry, the challenge of MCT, 
learning a new relationship with their thoughts, and thereby gaining a feeling of freedom to live their lives.  
1.1 The starting point: ‘caught in a spiral of worry’ 
When recalling life before starting MCT, participants consistently described being “caught in a spiral 
of worry”, going “round and round in circles”, “suffocating” or becoming “utterly exhausted”, “helpless”, 
“hopeless” and “engulfed” or “overwhelmed” by worry. Worry centred on cancer and its consequences for 
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themselves and others, and on what could be done to mitigate risk of recurrence. For many, worrying was 
linked to extensive Internet searching. For example, P23/0 described “looking at the death statistics to try 
and work out where I thought I was on the graph” even though “it was just doing me no good. Absolutely 
nothing from doing that was doing me any use at all”. Every participant worried also about concerns distinct 
from cancer, including financial problems, family members’ illness and neighbour disputes. P12/3 
illustrated how participants described worrying to try to mitigate challenges: “The way I got through my 
day was having everything controlled…What I used to do was overthink what was coming. ‘This might 
happen, this might happen, Oh this could happen’. So I would try to work out what may or may not happen 
so that if it did happen then I’d pre-thought it through and…I’d be able to handle it better”. Some 
participants, like P3, described worrying about worry: “I’ve said it before to [oncologist] and to [nurse]: 
‘I’m convinced I’m making myself ill. I’m making myself ill because I am stressing that much and that isn’t 
good for the cancer.’”  
1.2 Doubt and challenge in learning MCT  
1.2.1 ‘My worry is part of me, and MCT will be too brief to change me’ 
A few participants, like P15/0, recalled being “curious” and “hopeful” before starting MCT, or thought 
that “it’s got to be better than nothing” (P18/0). In general, however, participants began MCT “sceptical 
as to such a short sort of programme being able to fix me…I felt like my anxiety was just intrinsically part 
of who I was” (P2/0).  
Participants linked their scepticism to the challenge that MCT presented to their belief that they could 
not control worrying. P12/0 thought the explanation of MCT at the start of therapy “was almost quite 
naïve…too simplistic to assume that you can switch it [worry] off”. P31/0 described MCT as “scary 
initially, because I was always under the impression that I couldn’t control these, these thoughts and I had 
to pay attention to them”. Several participants had received therapy previously, and spontaneously cited 
their experience to support their belief that they could not change (Table 2).  
1.2.2 The psychologist provides 'challenge’, not ‘support’ 
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Once participants started MCT, they consistently experienced it as “challenging”, “mentally 
demanding”, “hard work”, “tiring” or even “gruelling”. For example P2/0 recalled her first session as 
“really exhausting… [I left] feeling like I’d like ran a marathon…I remember crying a lot and it was very 
challenging. I think I was really exhausted at the end of it…because it just completely challenged a lot of 
beliefs”. Similarly, P7/3 described MCT as “like retraining your brain rather than learning 
something…And in a way going to the gym is hard work and you don’t want to do it. It’s the same I think.”  
Given their doubts, and the challenge associated with MCT, participants consistently attributed their 
continued participation to the psychologist. When explaining how the psychologist helped, only P1/0 
referred to feeling emotionally supported, recalling the psychologist explaining that P1 was “not the only 
one” to have feelings of guilt and anger, making her feel “comfortable” and “relaxed” and becoming a 
“crutch”. By contrast, all other participants, and also P1/0 elsewhere in her interview, emphasized the 
psychologist’s didactic or “challenging” role, describing her “telling”, “teaching” or “explaining”. Several 
referred explicitly to challenging questioning; for instance when “I said that…I couldn't control the worry. 
And [psychologist] was asking me things like ‘Do you worry when you sleep? Do you worry when you're 
doing other things? Do you worry when you're with your daughter?’…I'm like, ‘Well, no, no I don't do it 
then.’ And she said, ‘But you say here that you worry 100%, all the time, nonstop.’...And then she would 
say things, ‘Well who's controlling the worry?’ ‘Who is the one who is worrying and who is controlling it?’ 
And I thought, ‘It's me.’” (P9/0). Several participants contrasted their experience of MCT with prior 
experience of counselling (Table 2), emphasizing in particular the psychologist’s “structured” and 
“challenging” approach and explaining that benefits of MCT therefore endured beyond the relationship 
with the psychologist. None described wanting more support or understanding from the psychologist, and 
none recounted any feelings resembling abandonment at the end of therapy.  
1.3 A new relationship with thoughts: ‘they’re only thoughts’ 
Participants who met the criterion for improvement all recounted learning a new relationship with their 
thoughts, with three defining features: they recognized that thoughts would pass if they allowed them to, 
and were not problems in themselves to be addressed; they explained that feelings of worry or sadness were 
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a normal part of life that they could accept rather than fight; and they felt in control of whether and how 
they engaged with their thoughts.  
1.3.1 ‘Let thoughts pass’ 
Participants consistently described having learned, when thoughts that used to trigger worry and 
rumination arose, “don’t fight it” or “don’t latch onto it" and, instead, "let it pass"; “it’s only a thought”. 
As P6/0 explained, “the biggest lesson I’ve learned is when your thoughts come to you, you don’t try to 
dispel it. You don’t fight…don’t try and solve it. You just…let it pass.”  Participants attributed their ability 
not to engage with these thoughts or images to appreciating that they are “like other thoughts in your head 
all through the day… [that] will go, will pass” (P7/0). They recognized that the thoughts were not in 
themselves problems that required solutions, nor were they dangerous. For P12/0, “my biggest battle was 
accepting that… the thoughts [about cancer recurrence] won’t cause cancer”.  
Participants recounted insights about worrying, also. They consistently described learning that worry 
was not useful, for instance, that “worrying about something is not going to prevent it happening…I believe 
that now” (P1/0). Some described having learned not to be frightened of their own worry. For instance, 
P2/3 described having learned “that I didn’t have to be scared of the feelings when they came…It was kind 
of like a light switch that was sort of like, I don’t have to be scared of that [worry] anymore and, you know, 
it’s not going to hurt me”.  
1.3.2 ‘It’s normal to have upsetting thoughts at times’  
Participants learned to recognize that many of the thoughts and feelings that previously triggered worry 
and rumination concerned real challenges or memories that it was natural to feel upset or unhappy about, 
but that they need not worry about feeling upset or unhappy. For instance, P12/3 explained that, “[Before 
therapy], I always used to try and say to myself ‘Oh snap out of it [low mood], stop doing it [worrying]’, 
you know, and was very negative towards myself, almost feeling was though I was a failure because I 
couldn’t…control the thoughts. And I think now I’m much more accepting that it’s normal to have these 
thoughts that will pop into your head”. Most participants experienced distressing thoughts associated with 
their continuing vulnerability to cancer throughout the period of therapy and follow-up, particularly when 
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anticipating scans or scan results and, after MCT, they consistently recognised that it was normal to be 
upset in those circumstances and that they need not worry about being upset. For instance, P3/0 reflected 
that “I think I’m going to be upset about [a forthcoming scan]…because I think it’s natural to feel that if 
you walk into a room and know you could be getting a life-changing decision. I feel OK about it to be honest 
with you”.  
However, participants recounted diverse challenges arising during the period of therapy and through 
follow-up that were not directly related to their cancer, including relationship problems, and serious illness 
in family or friends.  Those who met our criterion for improvement consistently described having learned 
to accept upsetting thoughts at such times as normal responses to such challenges that did not need to be 
resisted or controlled. For instance, in recounting diverse challenges at 3-months follow-up, including a 
friend’s death, becoming pregnant and moving house, P2/3 explained that “As the things have happened 
I’ve just let them…My friend dying was the big big big big one, and you know that’ll stay with me but…I’ve 
just kind of existed with it…I haven’t really fought against anything...It’s not that I haven’t had them [low 
moments], I just haven’t done my habitual, sort of, catastrophizing”. Similarly, P3/0 spoke about her 
sadness at learning that a relative was incurably ill: “I appreciated the fact I could have a normal emotion 
about it and I didn’t have to control it…I didn’t try and stop the sadness because I thought ‘Well you know 
at the end of the day it is a sad situation and I’m allowed to be sad’”. 
Participants who had received previous psychological therapy spontaneously and strikingly contrasted 
their new ability to accept troubling thoughts and feelings as normal with the disavowal of those thoughts 
and feelings that they associated with previous therapy (Table 2). 
1.3.3 ‘I can control how I react to my thoughts’ 
Whereas participants all described having felt “out of control” of worry before MCT, they consistently 
referred to having gained a sense of agency after completing therapy. They used phrases like “I have 
decided”, “I’m in control” or “I’m not going to do that” to describe their “decision” not to engage with 
thoughts or feelings that used to trigger worry. P9/3 explained that “I wouldn’t say I’m in control of my 
thoughts, because I’ve got no control over them, but I can control over what I do about them”. P15/0 
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described how MCT “gave me the awareness that I could choose...to react differently [to thoughts]”, 
explaining that “one [exercise] that was very helpful for me was the ‘You don’t have to pick up the phone 
when it rings’. I found that quite useful, or ‘Actually I can deal with that [thought] later, I don’t have to 
deal with it right now, so I can put it on the backburner’...It’s the realisation you don’t have to go with 
it...there’s a choice involved in how you do it”. Participants spoke about the confidence that this sense of 
control gave them in an inherently uncertain context in which upsetting or challenging events arose 
unpredictably. For instance, at 3-month follow-up, P1’s sense of vulnerability to recurrence of her breast 
cancer had been heightened by two friends’ recent discoveries of incurable metastases associated with their 
own breast cancer. She felt that the MCT “is helping me to control my mind…All this mental therapy is 
preparing me for the medical side of it for when it [her own cancer] comes back…I feel like I can trust…the 
mental side of it but I don’t feel I can trust the medical side of it”. Thoughts about her vulnerability were 
therefore “frustrating” rather than, as previously, “overwhelming”.  
Participants sense of their own agency extended retrospectively; that is, after therapy, they appreciated 
that their previous distress had been “self-generated”: “You’ve done this to yourself. It’s not an illness”. 
However, no participant described feeling blame or guilt. They were protected because “I wasn’t realising 
that that’s what it was” (P2/0), but also because MCT explicitly taught them not to engage with such 
thoughts. Several participants explicitly contrasted this understanding from MCT with the culpability that 
they felt previous therapy had implied (Table 2).  
[Please insert Table 2 here] 
1.4 The benefit of therapy: ‘I can live my life now’ 
After MCT, participants who improved consistently reported feeling “happier” and “free” to “enjoy 
life” and “live instead of function”. Central to this newfound freedom was deciding what they could and 
could not influence. Participants described not trying to pre-empt events they could not change; that is, 
“taking things as they come”. However, they had not simply learned to acquiesce to events. Instead, they 
describing feeling “free to make decisions” or “putting myself first” where they could.  
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1.4.1 ‘I’ll take things as they come’  
Participants who met our criterion for clinically-significant improvement consistently described 
accepting that they had to live with uncertainty but need not worry about possibilities that they previously 
would have worried about. For instance, P31/6 reflected that “I don’t really dwell on what could happen…If 
it happens, it happens…You can’t say ‘Look I’ve had enough of this, don’t give me no more cancer’ or any 
of that…You just take it as it comes”. Most strikingly, participants took this attitude to the possibility that 
scans or investigations would reveal cancer recurrence. For instance, at 3-month follow up, P3/3 referred 
to her forthcoming scan: “I can’t change the scan [outcome]…If there’s anything there then I’ll deal with 
it, I’ll find out what the treatment plan is and that’s it. I won’t worry about it…I’m not living if I’m worrying 
or stressing about it”. Similarly, at 6 months follow-up, P9/6, whose cytogenetic test results put her at high 
risk of recurrence, described waiting for recent scan results: “[Thought of recurrence] is just a thought. 
There’s no point in me worrying about this. This is a thought…And for the whole week that was popping 
in: ‘Someone’s looking at this MRI. The radiologist will be looking at this now’. That’s a thought, that’s 
OK…It’s just a thought. And whatever the outcome is of this MRI, I will deal with it then.” Several 
participants described developing reasoned strategies for when to seek investigation for symptoms that 
might signify recurrence, without the intense worry that would previously have surrounded reminders of 
vulnerability. As P3/6 explained: “If I think I have a twinge I just do my normal checks and just think ‘that’s 
nothing to worry about’…I had a twinge the other day. And I did say to my husband ‘Listen I’ve had a 
twinge, and if it’s still there in four days’, you know, give myself a deadline, ‘I’m going to get onto them’. 
And I’ve not had it since, so I was just quite sensible about it…The fact that it’s been there one day, I’m 
not going to worry about it.”  
1.4.2 ‘I’m free to put myself first’ 
After MCT, participants described “putting myself first” where they could, and having time to do ‘the 
practical things… [which] previously I didn’t really have the time to do because most of the time was spent 
worrying, feeling I had to worry” (P9/3).  Several recounted major life changes. For instance, at 3 months, 
P23/3 had become able to “fill my thoughts with better things like the future”; at 6 months she had “made 
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that decision [to resign a highly paid but demanding job]…because I’m actually now thinking about the 
future which I wasn’t [before MCT]”. In the same vein, participants reported booking holidays that they 
had previously avoided lest forthcoming scans revealed problems (P12/3; P3/6), taking on new, more 
challenging, roles at work (P3/6), allocating more time to friends and family (P9/6; P19/6; P31/6), and 
deciding to prioritise their own needs rather than acquiescing to others’ demands (P12/6).  
2. Participants who did not complete therapy or did not consistently improve 
Those participants who did not complete therapy, or who completed it but without meeting our criterion 
for clinically-significant improvement, formed a heterogeneous set, both in their clinical response to MCT 
and in their interviews. All described the same starting point as those participants who made clinically-
significant improvement; that is, against a background of feeling that life was dominated and constrained 
by worry, they recalled being initially sceptical about MCT and described early sessions as “hard work” 
because the psychologist challenged entrenched beliefs about worry. However, neither of the participants 
who withdrew from treatment (P13, P14) indicated any understanding of MCT, describing it simply as “to 
help me understand the cancer side of things and to show I wasn’t alone” (P13/0) or “trying to boost my 
self-esteem” (P14/0). They each described MCT as too ‘stressful’ or ‘intense’. By contrast, all four 
participants who completed MCT, but without meeting our criterion for improvement, appeared to 
understand the model, for instance summarising its goal as “not to have dialogue with thoughts anymore” 
(P30/0) because “the whole process of engaging, either through rumination or worry, is then you do end 
up with further worry, further rumination, more thoughts, a whole process of thoughts that lead you down 
a path to depression, basically” (P21/0). Similarly, their accounts of what they had learned about MCT 
resembled those of participants that were successfully treated: “I can’t control my thoughts but I can control 
what I do with them and, and whether worry or rumination happens with them” (P16/0). However, these 
participants found it difficult to apply what they had learned. Two gave clues as to what was difficult, 
describing successfully disengaging from some thoughts but not others, particularly ones related to family 
roles. For instance, P11 described having “more powerful thoughts [concerning her children’s long-term 
health conditions]…that I can't seem to just let go of…that I'm finding difficult to be able to just go, ‘Yeah, 
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it's a thought’” (P11/0). Similarly, although P21 could apply MCT to thoughts about the potential for cancer 
recurrence, she could not apply it to her angry thoughts about her partner, describing feeling “adrift” and 
“conflicted” about the future of her relationship.   
DISCUSSION 
Overview 
All participants described feeling consumed by worry before starting therapy, doubting that such 
brief therapy could help them, and feeling intensely challenged to think differently by the psychologist 
providing MCT. All those who completed therapy described learning a new relationship with their own 
thoughts and gaining a sense of freedom to live lives free from worry about cancer and other challenges of 
survivorship. However, those who did not consistently improve described being unable to apply MCT to 
particularly troubling thoughts. Two participants who withdrew before completing MCT did not describe 
having learned what MCT was intended to achieve.  
Results in relation to previous literature  
Consistent with the qualitative accounts of most of the participants who completed therapy, findings 
of the open trial examining the potential of MCT to alleviate emotional distress in adult cancer survivors 
were promising (Fisher et al., 2019).  MCT can be delivered as a transdiagnostic intervention which appears 
to reduce multiple forms of distress across a heterogenous group of cancer survivors.  By contrast with 
other psychological approaches in cancer care, MCT is the only one which directly focuses on 
metacognitive beliefs and processes to alleviate distress. Although “third wave” approaches (ACT, MBCT 
and MBSR) do not predominantly focus on the content of patients’ thoughts, all incorporate  greater 
discussion of cancer related thoughts than does MCT.  Furthermore, MCT does not require patients to apply 
coping strategies which require continued conceptual processing of negative thoughts. 
Participants’ awareness of how worry and rumination contributed to emotional distress  was the key 
to their experiences of MCT. Before starting therapy, participants regarded worry as ‘part of who I was’ 
and doubted that it would help them. For some, doubts related to the brief duration of the intervention; for 
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others, prior experience of unsuccessful therapy left them pessimistic. Nevertheless, reservations 
diminished among participants who continued therapy as they described learning that they need not engage 
with distressing thoughts. They learned to question their beliefs that worry and rumination were necessary 
or dangerous and they learned that distressing thoughts were ‘normal’ and need not trigger attempts to 
control them; that is, participants described becoming effectively ‘socialised’ to the MCT model (Wells, 
2009). After receiving MCT, participants were positive beyond polite acquiescence with the interviewer, 
usually effusively so as they described feeling able to live their lives and make decisions for the future. 
Contrary to previous qualitative evaluations of cancer patients’ experiences of CBT and relaxation therapy 
(Hoeck, Ledderer, & Ploug Hansen, 2017), participants had a clear understanding of the aims of therapy, 
and no participant indicated an unmet need to address the content of their worries. Indeed, those with 
previous experience of content-focused therapies contrasted them negatively with MCT. In particular, most 
participants who completed therapy valued learning to accept negative thoughts and feelings as appropriate 
responses to negative life events, by contrast with previous CBT or counselling in which they had felt 
expected to deny the validity of those experiences.  
 Experiences of the clinical relationship were also in striking contrast with the way in which this is 
portrayed in psychological care generally, and cancer care particularly, in which the psychologist’s empathy 
and supportive role are central (Boulton et al., 2001; MacCormack et al., 2001; Rogers, 1951). Participants 
who completed therapy did not describe relying on their psychologist for support but, rather, valued being 
challenged to think differently and question long-held beliefs about worry and rumination. Moreover, 
despite the focus of MCT on developing metacognitive awareness rather than a therapeutic alliance, none 
of the participants who continued therapy indicated any unmet need for the psychologist’s understanding 
or acceptance, nor did they report feeling ‘abandoned’ at the end of therapy, despite therapy being relatively 
brief. There is little information regarding how cancer patients feel after other types of psychological 
therapy, but what there is indicates that feelings of abandonment are a feature of patients’ experiences of 
CBT and relaxation therapy (MacCormack et al., 2001). Our findings indicate that this is an area that needs 
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further research, particularly given the emphasis placed on the importance of longer-term, supportive 
therapies in cancer care (Boulton et al., 2001; MacCormack et al., 2001; Rogers, 1951). 
Participants who met our criterion for improvement consistently described being able to apply what 
they had learned beyond the duration of therapy. Those who had received other therapies explicitly 
contrasted MCT with those experiences of therapy which, they felt, had provided no long-term benefits. In 
addition, participants described generalizing their ability not to engage with thoughts to those arising across 
the diverse range of challenges associated with survivorship, from anticipation of impending scans, through 
fears of recurrence and death, to challenges unconnected with cancer, including relationship problems and 
other peoples’ illnesses. It seems that, by being challenged to recognize their absence of control over some 
events, but their control over how they responded to thoughts about those events, participants who improved 
had acquired an understanding that they could apply very generally, without continuing reference to the 
psychologist. These participants therefore described feeling a sense of empowerment after completing 
therapy, and consistently referred to gaining a sense of agency and responsibility for their own distress. 
This extended retrospectively, as participants who improved freely described appreciating that they had 
been responsible for their distress. However, no participant described feeling blame or guilt over this 
responsibility; they explained instead that MCT had taught them not to engage with such thoughts. One 
participant contrasted having learned from MCT to take responsibility for his distress with his experience 
of CBT, in which he felt both both responsible and blamed. However, the only study that, to our knowledge, 
has examined cancer patients’ experiences of CBT (MacCormack et al., 2001) did not find that feelings of 
either responsibility or blame were salient features of patients’ experiences. Our findings suggest that the 
role of agency and control in understanding the effects of psychological therapy in cancer care is an area 
that needs more research.  
Four participants who completed therapy did not meet our criterion for clinically-significant 
improvement. Although these were indistinguishable from the participants who did meet the criterion in 
the way they described learning a new relationship with their thoughts, each described failing to generalise 
what they had learned across the range of thoughts that distressed them. From an MCT perspective, it seems 
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that these participants continued to label certain thoughts as ones they could not, or did not want to, 
disengage from. Whilst it is possible that psychologists more experienced in delivering MCT could have 
helped these participants to generalize MCT more widely, there may be certain patient characteristics which 
militate against generalization but which our study did not identify. Future quantitative studies could 
investigate this further, for instance by examining whether previous history of psychological morbidity or 
adversity moderates treatment effects.   
Seven patients in the open trial did not complete the course of therapy. Each of the two whom we 
could interview described MCT as too ‘stressful’ or ‘intense’ for them to continue; both had previously 
received counselling and spoke about MCT in a way that suggested that they expected a similarly 
supportive, non-directive intervention. However, we know nothing about the perspectives of the remaining 
five participants that did not complete therapy; in particular, we do not know whether participants who had 
no prior experience of counselling also came with these expectations. The possible importance of patients’ 
expectations of therapy in their readiness to accept MCT needs further research.  
Strengths and limitations  
As a qualitative study of a sample of patients from one UK centre, our findings cannot necessarily 
be generalised. Moreover, our participants were self-selected and mostly White British females, reflecting 
the profile of referrals to the psycho-oncology service. However, we aimed to minimise researcher selection 
by offering entry to the open trial to all suitable consecutive patients, and then inviting for interview all 
participants who completed therapy and could be categorized as improved as well as all those who could 
be categorized as not improved. Although we made strenuous efforts to interview those who did not 
complete therapy, we were only able to obtain brief interviews with two from this important group and 
therefore have little information about why cancer survivors might withdraw from MCT. We thereby 
recruited a sample of cancer survivors who presented with a diverse range of pre-treatment difficulties 
including fear of cancer recurrence, post-traumatic stress symptoms, bereavement, depression and anxiety. 
We did not have ethical approval to interview those that did not consent to the trial. Although our analysis 
was inevitably shaped by the perceptions and experience of the research team, we strenuously disputed 
22 
 
different interpretations of the data and, through our diverse backgrounds in MCT, CBT, and emotional and 
patient perspectives, brought different viewpoints to the analysis.   
Implications 
Our findings can inform randomised evaluations of MCT for distressed cancer survivors. In 
particular, although MCT was an acceptable intervention for most participants, a quarter did not complete 
therapy and we have little information about their reasons. To reduce attrition some patients, particularly 
those with prior experience of supportive counselling, might need to be helped to prepare for the 
‘challenging’ nature of MCT. In addition, more attention will be needed to style of delivery, particularly in 
early sessions. For instance, it may be better to use gentler questioning to challenge beliefs until patients 
are socialised to the MCT model. Around a fifth of patients who completed treatment were not consistently 
improved across the post-therapy and followup assessments, and future trials will need to characterize this 
group further.   
Nevertheless, our findings point to the need to question important assumptions that underlie the 
broader field of psychotherapy in cancer care. First, it is widely assumed that the psychological complexity 
that cancer survivors present necessitates an integrative framework in which different therapeutic models 
are combined to match the range of patients’ needs (Boswell, Nelson, Nordberg, McAleavey, & 
Castonguay, 2010; Curran, Sharpe, & Butow, 2017; Wells & Fisher, 2015). For instance, most recently, 
Curran’s integrated model of anxiety (Curran et al., 2017) proposes that psychologists draw from models 
including CBT, MCT, ACT, cognitive-processing therapy and existential therapy, when working with 
cancer survivors experiencing anxiety and fear of cancer recurrence. Our data, instead, point to the 
potentially broad clinical utility of a single model which helps patients to understand, in an accessible and 
simple way, processes that maintain their emotional distress, irrespective of the nature of their presenting 
difficulties (Wells, 2009).  
Second, our findings challenge the commonly-held belief across psychotherapeutic professions that 
a therapeutic relationship must be anchored in non-specific, relational Rogerian principles of empathy, 
supportive listening and trust, and should be prioritised and fostered before meaningful therapeutic change 
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can occur (Boulton et al., 2001; MacCormack et al., 2001; Rogers, 1951). Our participants’ experiences 
indicate that a therapeutic relationship formed as the patient became socialized to the therapeutic model, 
and developed as participants witnessed their own progress. Therefore, for most patients, psychologists 
might not need to address the therapeutic relationship explicitly beyond working in a collaborative and 
Socratic manner (Byrne, Salmon, & Fisher, 2018). However, these findings arose in the context of MCT, 
and it remains to be seen whether patients engaging with other process-focused models would have similar 
experiences.  
Conclusions  
Despite the widely accepted importance of using qualitative findings to understand how patients 
experience interventions (i.e. to understand their ‘face validity’), and to inform future intervention 
development, evaluation and delivery (Craig et al., 2008), our study is one of few published evaluations of 
patients’ experiences of psychotherapy in cancer care. Although the findings of this longitudinal qualitative 
study will inform future controlled trials of MCT, they also more broadly challenge current assumptions 
about psychotherapy in cancer care. Future qualitative studies are needed to evaluate whether these findings 
are unique to MCT, or apply more broadly to processed-focused psychotherapeutic approaches.  
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